These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29995878)

  • 1. Usefulness of the frequency-volume chart over the International Prostate Symptom Score in patients with benign prostatic hyperplasia in view of global polyuria.
    Yoo S; Park J; Cho SY; Cho MC; Jeong H; Son H
    PLoS One; 2018; 13(7):e0197818. PubMed ID: 29995878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia.
    Yokoyama O; Ozeki A; Suzuki N; Murakami M
    Int J Urol; 2018 Mar; 25(3):240-245. PubMed ID: 29094398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study).
    Montorsi F; Gandaglia G; Chapple C; Cruz F; Desgrandchamps F; Llorente C
    Int J Urol; 2016 Jul; 23(7):572-9. PubMed ID: 26969887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
    Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Visual Prostate Symptom Score with International Prostate Symptom Score and Uroflowmetry Parameters in Nepalese Male Patients with Lower Urinary Tract Symptoms.
    Bhomi KK; Subedi N; Panta PP
    JNMA J Nepal Med Assoc; 2017; 56(206):217-220. PubMed ID: 28746318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: a prospective open-label long-term study using frequency-volume chart.
    Kojima Y; Sasaki S; Imura M; Kubota Y; Hayashi Y; Kohri K
    Neurourol Urodyn; 2012 Jan; 31(1):80-5. PubMed ID: 22038792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia.
    Sciarra A; D'Eramo G; Casale P; Loreto A; Buscarini M; Di Nicola S; Seccareccia F; Di Silverio F
    Prostate; 1998 Feb; 34(2):121-8; discussion 129. PubMed ID: 9465943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study.
    Wang CJ; Lin YN; Huang SW; Chang CH
    J Urol; 2011 Jan; 185(1):219-23. PubMed ID: 21074790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms.
    Barry MJ; Cantor A; Roehrborn CG;
    J Urol; 2013 Mar; 189(3):987-92. PubMed ID: 23017510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men?
    Otunctemur A; Ozbek E; Besiroglu H; Dursun M; Sahin S; Koklu I; Erkoc M; Danis E; Bozkurt M; Gurbuz A
    Int J Urol; 2014 Dec; 21(12):1268-72. PubMed ID: 25056570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
    Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
    J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Debilitating lower urinary tract symptoms in the post-renal transplant population can be predicted pretransplantation.
    Dion M; Cristea O; Langford S; Luke PP; Sener A
    Transplantation; 2013 Feb; 95(4):589-94. PubMed ID: 23263609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of nocturia by analyzing frequency volume chart and relations with international prostate symptom score in male patients with lower urinary tract symptoms in Korea.
    Choi YS; Kim JC; Kim YH; Choi JB; Park WH; Lee DH
    Investig Clin Urol; 2019 Jul; 60(4):267-274. PubMed ID: 31294136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.
    Ito H; Sano F; Ogawa T; Yao M
    Int J Urol; 2014 Jan; 21(1):108-12. PubMed ID: 23662900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia.
    Kwon JK; Han JH; Choi HC; Kang DH; Lee JY; Kim JH; Oh CK; Choi YD; Cho KS
    BJU Int; 2016 Feb; 117(2):316-22. PubMed ID: 25807886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of benign prostatic hyperplasia among men in Japan: Patient-reported outcomes among those diagnosed and experiencing symptoms.
    Yoshida M; Flores NM; Vietri J; Lee M; Murakami M
    Int J Urol; 2015 Oct; 22(10):949-55. PubMed ID: 26138017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.